| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/26/2011 | US20110124695 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
| 05/26/2011 | US20110124693 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases |
| 05/26/2011 | US20110124680 Novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors |
| 05/26/2011 | US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors |
| 05/26/2011 | US20110124670 Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis |
| 05/26/2011 | US20110124666 3,4-dihydropyrimidine trpa1 antagonists |
| 05/26/2011 | US20110124653 Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 05/26/2011 | US20110124650 Stable crystalline salts of antifolate compounds |
| 05/26/2011 | US20110124641 Benzothiazole kinase inhibitors and methods of use |
| 05/26/2011 | US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 05/26/2011 | US20110124621 Benzothiazoles as ghrelin receptor modulators |
| 05/26/2011 | US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 05/26/2011 | US20110124615 Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 05/26/2011 | US20110124613 Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma |
| 05/26/2011 | US20110124589 Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease |
| 05/26/2011 | US20110124583 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 05/26/2011 | US20110124580 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/26/2011 | US20110124569 Macrocyclic compounds, protease inhibition, and methods of treatment |
| 05/26/2011 | US20110123646 Extracts Obtained from Cell Line Cultures from Plants Belonging to the Oleaceae Family (e.g. Syringa Vulgaris), Their Preparation and Use |
| 05/26/2011 | US20110123626 Pulmonary delivery of a fluoroquinolone |
| 05/26/2011 | US20110123619 Buccal delivery system |
| 05/26/2011 | US20110123595 Personal Stimulating Wiping Systems |
| 05/26/2011 | US20110123574 Inhalable sustained therapeutic formulations |
| 05/26/2011 | US20110123571 Use of bacterium for manufacture of a vaccine |
| 05/26/2011 | US20110123547 Compounds Having CRTH2 Antagonist Activity |
| 05/26/2011 | US20110123530 Compositions and methods for treating and diagnosing asthma |
| 05/26/2011 | US20110123525 Anti-angiogenic therapy |
| 05/26/2011 | US20110123518 Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid |
| 05/26/2011 | US20110123512 Method of regulating the heat shock response |
| 05/26/2011 | US20110123495 Derivatives of pyridone and use thereof |
| 05/26/2011 | US20110123449 Solid Forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide |
| 05/26/2011 | CA2781061A1 Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom |
| 05/26/2011 | CA2781012A1 Inhalation solutions |
| 05/25/2011 | EP2325300A1 Desaturase genes and uses thereof |
| 05/25/2011 | EP2325205A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 05/25/2011 | EP2324851A1 Methods of administering anti-TNFalpha antibodies |
| 05/25/2011 | EP2324834A2 Methods of Increasing Endogenous Erythropoietin (EPO) |
| 05/25/2011 | EP2324831A1 Methods of administering pirfenidone therapy |
| 05/25/2011 | EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
| 05/25/2011 | EP2324827A1 Therapeutic agent for anca-related vasculitis |
| 05/25/2011 | EP2324825A1 Aryl ureas with angiogenesis inhibiting activity |
| 05/25/2011 | EP2324022A1 Substituted naphthyridines and use thereof as medicines |
| 05/25/2011 | EP2323980A1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases |
| 05/25/2011 | EP2323675A2 Compositions comprising lactobacillus casei for improving resistance to common infectious diseases |
| 05/25/2011 | EP2323656A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist |
| 05/25/2011 | EP2323655A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient |
| 05/25/2011 | EP2323653A1 2-hydroxy-ethanesulfonate salt |
| 05/25/2011 | EP2056805B1 Use of 2, 5-dihydroxybenzene derivatives for the treatment of tissue reactive diseases |
| 05/25/2011 | EP2021335B1 Heterocyclic compounds as inhibitors of c-fms kinase |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1349562B1 Inhibiting gs-fdh to modulate no bioactivity |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | CN1913872B Pre-metered dry powder inhaler for moisture-sensitive medicaments |
| 05/25/2011 | CN102076682A Five-membered ring compound |
| 05/25/2011 | CN102076672A Novel five-membered ring compound |
| 05/25/2011 | CN102076661A Antagonists of prostaglandin d2 receptors |
| 05/25/2011 | CN102076344A Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 05/25/2011 | CN102071239A Anti-tumor mung bean polypeptide, preparation method thereof and application thereof to tumors |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070631A Quaternary ammonium salt of penehyclidine optical isomer, medicinal composition and medical application thereof |
| 05/25/2011 | CN102070630A New tiotropium salts, pharmaceutical compositions containing the same and use thereof |
| 05/25/2011 | CN102068683A Chinese medicinal preparation for treating rhinitis |
| 05/25/2011 | CN102068667A Chinese medicine composition with clearing heat and detoxicating functions |
| 05/25/2011 | CN102068626A Quality control method for infantile cough syrup as Chinese medicine preparation |
| 05/25/2011 | CN102068622A Chinese medicinal herb for treating rhinitis |
| 05/25/2011 | CN102068602A Chinese medicine formula for treatment of chronic pharyngitis |
| 05/25/2011 | CN102068601A Chinese medicinal formula for treating chronic tonsillitis |
| 05/25/2011 | CN102068599A Quality control method for phlegm eliminating and asthma relieving cough syrup |
| 05/25/2011 | CN102068546A Chinese medicament for treating pulmonitis |
| 05/25/2011 | CN102068507A Preparation method of Chinese medicinal capsules for tonifying lung and activating blood circulation |
| 05/25/2011 | CN102068506A Sterilizing and antimicrobial Chinese medicinal disinfectant |
| 05/25/2011 | CN102068501A Black pepper extract, preparation method thereof and application in preparation of medicaments for preventing and treating cough |
| 05/25/2011 | CN102068472A Preparation method for traditional Chinese medicinal pubescent holly root injection |
| 05/25/2011 | CN102068463A Preparation method of traditional Chinese medicine emulsion |
| 05/25/2011 | CN102068460A Earthworm protein-containing buccal instant preparation, preparation method and application thereof |
| 05/25/2011 | CN102068452A Antiviral medicinal composition |
| 05/25/2011 | CN102068450A Application of aucubin to preparation of anti-thrombosis medicament |
| 05/25/2011 | CN102068447A Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases |
| 05/25/2011 | CN102068426A New application of Ginkgolide B derivative in medicament preparation |
| 05/25/2011 | CN101773580B Traditional Chinese medicine composition for curing infantile acute bronchitis and preparation method |
| 05/25/2011 | CN101732424B Chinese medicinal powder for treating pharyngitis |
| 05/25/2011 | CN101675923B New usage of zedoary cyclic diolefine |
| 05/25/2011 | CN101612200B Method for preparing plant mulberry vinegar pure solution and application thereof in treating rhinitis |
| 05/25/2011 | CN101579315B Immunoliposome based on endostatin gene, preparation method and application thereof |
| 05/25/2011 | CN101543601B Compound pharmaceutical composition for preventing and curing respiratory diseases in animals and preparation method thereof |
| 05/25/2011 | CN101543545B Traditional Chinese medicine preparation for curing rhinitis and quality control method thereof |
| 05/25/2011 | CN101518613B Chinese herbal decoction for treating cough |
| 05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 05/25/2011 | CN101401876B Chinese medicinal composition for treating upper respiratory tract infection |
| 05/25/2011 | CN101249212B Externally used drug for curing epidemic parotitis |
| 05/25/2011 | CN101228968B Cigarette additive decreasing smoke gas harm |
| 05/25/2011 | CN101219201B Traditional Chinese medicine liquid capsule and its preparing method |
| 05/25/2011 | CN101185759B Anti-angiogene compositions and methods of use |
| 05/25/2011 | CN101152255B Method of preparing aqueous extract concrete of ficus microcarpa leaf |
| 05/24/2011 | US7947730 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | US7947693 5,7-disubstituted thiazolo[4,5-D]pyrimidines as chemokine inhibitors |
| 05/24/2011 | US7947692 Substituted thiazolo[5,4-d]pyrimidine urea derivatives |
| 05/24/2011 | US7947684 anticoagulants; immunomoderators; antiinflammatory agents |
| 05/24/2011 | US7947273 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma |